Bookmark

Add to MyYahoo RSS

HiTech Pharmacal Co News

News on HiTech Pharmacal Co (Ticker: HITK) continually updated from thousands of sources around the net.

Jun 23, 2014 | Pharmaceutical Processing

Akorn Divests ECR Pharmaceuticals to Valeant

Akorn has sold its subsidiary, ECR Pharmaceuticals, to Valeant Pharmaceuticals for $41 million in cash and assumption of certain liabilities.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

Fri Jun 20, 2014

Holtville Tribune

FTC Approves Final Order Settling Charges That Akorn Enterprises' Acquisition of Hi-Tech Pharmacal Was Anticompetitive

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Akorn Enterprises' $640 million acquisition of Hi-Tech Pharmacal, Inc. was anticompetitive and would lead to higher prices for consumers in several current and future generic drug markets.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

Tue Jun 17, 2014

Hispanic Business

Intellectual Property Infringements and Supply Chain Vulnerabilities...

Amid uncertainties around patent protection and lawmakers putting an indefinite hold on patent reform legislation, life sciences companies are increasingly pointing to intellectual property infringement as a threat.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••